
DM-NOFD
CAS No. 865488-53-5
DM-NOFD( Dimethyl ester NOFD | N-oxalyl-d-phenylalanine )
Catalog No. M16287 CAS No. 865488-53-5
The dimethyl ester of N-oxalyl-d-phenylalanine (NOFD), a specific HIF asparaginyl hydroxylase (FIH) inhibitor with Ki of 83 uM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
![]() ![]() |
50MG | 1782 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameDM-NOFD
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe dimethyl ester of N-oxalyl-d-phenylalanine (NOFD), a specific HIF asparaginyl hydroxylase (FIH) inhibitor with Ki of 83 uM.
-
DescriptionThe dimethyl ester of N-oxalyl-d-phenylalanine (NOFD), a specific HIF asparaginyl hydroxylase (FIH) inhibitor with Ki of 83 uM, but not HIF prolyl hydroxylase (>1 mM); also shows lack of in vitro inhibitory activities against a panel of Jumonji-C containing proteins KDM3A, KDM4E, and KDM6B (IC50>20 uM); more efficiently reduces HIF1α CAD hydroxylation.
-
In Vitro——
-
In Vivo——
-
SynonymsDimethyl ester NOFD | N-oxalyl-d-phenylalanine
-
PathwayAngiogenesis
-
TargetHIF/HIF Prolyl-hydroxylase
-
RecptorHIF/HIF Prolyl-hydroxylase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number865488-53-5
-
Formula Weight265.265
-
Molecular FormulaC13H15NO5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC)[C@@H](CC1=CC=CC=C1)NC(C(OC)=O)=O
-
Chemical NameDimethyl N-oxalyl-d-phenylalanine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chan MC, et al. J Biol Chem. 2016 Sep 23;291(39):20661-73.
2. McDonough MA, et al. J Am Chem Soc. 2005 Jun 1;127(21):7680-1.
molnova catalog



related products
-
Santalol
Santalol has good antibacterial, anti-oxidation and anti-tumor activities.
-
Oltipraz
Oltipraz (RP 35972, NSC 347901) is a cancer chemopreventive agent with inhibitory effect on angiogenesis and tumor growth.
-
TAT-cyclo-CLLFVY
Selective HIF-1 dimerization inhibitor. Blocks protein-protein interaction of recombinant HIF-1α, but not HIF-2α, with HIF-1β (IC50 = 1.3 μM). Inhibits hypoxia-induced HIF-1 activity, and decreases VEGF and CAIX expression in osteosarcoma and breast cancer cells in vitro. Also reduces tubularization of hypoxic HUVECs.